pharmaphorum

JULY 8, 2022

That spend is due to reach of $3 billion by 2025, according to GlobalData analyst Kitty Whitney, who notes that there has been a steady stream of startups formed in the last three to four years to tap into the emerging AI market. The post Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’ appeared first on.

Compounding 131

Compounding 131

PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

Pharmaceutical Technology

JUNE 26, 2025

Fi Forrest June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Shutterstock AI is revolutionizing drug discovery with its ability to analyze vast datasets. AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals.

Compounding 86

Compounding Drug Development Communication Packaging 86

Express Pharma

JANUARY 13, 2025

billion by 2033 at a compound annual growth rate (CAGR) of 23.4 Among a crowded late-stage pipeline of potential DMTs, Anavex Life Sciences ANAVEX2-73 (blarcamesine), presenting at the upcoming 2025 J.P. The global Alzheimers disease (AD) market across the eight major markets (8MM*) is forecast to grow from $2.4 billion in 2023 to $19.3

Compounding 104

Compounding 104

Drug Patent Watch

MARCH 18, 2025

billion by 2025, with a compound annual growth rate (CAGR) of 10.5%. billion by 2025, with a CAGR of 10.5%. The Russian pharma market has experienced significant growth in recent years, driven by a combination of factors, including government support, increasing healthcare spending, and a focus on domestic production.

Biosimilars 92

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Compounding 92

Pharmaceutical Technology

JUNE 24, 2025

Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Compounded drugs are custom-made and unbranded medications that contain the same active ingredient as a marketed drug.

Compounding 52

Compounding Packaging Online Pharmacies Communication 52

Pharma Marketing Network

JANUARY 16, 2025

Upcoming Informa Connect Events: Clinical Data Disclosure, Transparency and Plain Language Summaries February 25-26, 2025 Speaker Programs Summit March 3-5, 2025 Rare Disease Summit March 18-20, 2025 PAP Patient Assistance & Access Programs March 18-20, 2025 Hub and Specialty Pharmacy Models East March 18-20, 2025 Pharma Forum March 23-26, 2025 (..)

Specialty Pharmacies 40

Specialty Pharmacies Compounding Pharmacies Compounding 40

Pharma Marketing Network

JANUARY 16, 2025

Upcoming Informa Connect Events: Clinical Data Disclosure, Transparency and Plain Language Summaries – February 25-26, 2025 Speaker Programs Summit – March 3-5, 2025 Rare Disease Summit – March 18-20, 2025 PAP Patient Assistance & Access Programs – March 18-20, 2025 Hub and Specialty Pharmacy Models East – March 18-20, (..)

Specialty Pharmacies 40

Specialty Pharmacies Compounding Pharmacies Compounding 40

PharmD Live

JANUARY 15, 2025

The Centers for Medicare & Medicaid Services (CMS) has announced a 2.83% reduction in the Medicare Physician Fee Schedule (PFS) for 2025. Key Points of the 2025 PFS Reduction The 2025 PFS introduces a reduced conversion factor of $32.35, down from $33.29

Medication Therapy Management (MTM) 64

Medication Therapy Management (MTM) Hospitals Compounding 64

BioPharma Dive

JULY 9, 2025

Published July 9, 2025 Gwendolyn Wu Senior reporter post share post print email license Actinium is one of several radioisotopes favored by biotechnology companies developing drugs for cancer. The technology works by attaching a radioisotope to a targeting compound via a specially engineered “linker” molecule.

Drug Pricing 52

Drug Pricing Compounding Immunization Immunity 52

European Pharmaceutical Review

JUNE 19, 2025

This is compounded by “the lack of long-term evidence of effectiveness, together with the substantial resources the NHS would need to commit to the treatments means if they were approved they could displace other essential treatments and services that deliver significant benefits to patients,” continued Knight.

Compounding 52

Compounding 52

pharmaphorum

NOVEMBER 9, 2022

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 The alliance is backloaded, with $21.5 Currently, the time needed for a drug to reach the market ranges from 12 to 18 years, with an average cost of about $2.6

Compounding 111

Compounding Drug Development 111

PharmaTech

APRIL 6, 2025

3D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.

Compounding 59

Compounding 59

pharmaphorum

JUNE 12, 2025

These closures, compounded by the decline of independent pharmacies, create a critical gap in care. Image Maggie McCullough 12 June, 2025 pharmacy deserts Bookmark this Oncology ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bl. Oncology BioNTech’s ASCO 2025 oncology advances: New data on bispecif.

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

PhRMA

FEBRUARY 5, 2025

One of the largest compounders in the U.S., Hims & Hers, is spending millions of dollars to run a misleading Super Bowl ad that misrepresents their unapproved GLP-1 medicines.

Compounding 40

Compounding 40

FDA Law Blog: Biosimilars

SEPTEMBER 11, 2024

FDA says that highly potent compounds – again, as defined in ICH M7(R2) – pose risks below that limit. The revisions due in 2025 include testing for NDSRIs. Using the guidelines found in the ICH M7(R2) , FDA set an AI threshold of 1.5 We note that the other FDA guidance document on nitrosamines addresses NDSRIs.

Documentation 105

Documentation Compounding 105

pharmaphorum

JULY 14, 2025

View the full agenda here: [link] Image 14 July, 2025 Bookmark this R&D What to do when your grant application fails All hope should not be lost and an unsuccessful application doesn’t always mark the end of the road. Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

Pharmacy Times

JUNE 20, 2025

Related Videos Related Content Advertisement June 20th 2025 FDA Approves Dupilumb for Treatment of Bullous Pemphigoid Aislinn Antrim, Managing Editor May 28th 2025 Pharmacy Focus: Navigating Seasonal Allergies Luke Halpern, Assistant Editor Derek Webb, PharmD June 20th 2025 Self-Care Measures for Preventing and Managing Dysmenorrhea Yvette C.

Vaccines 29

Vaccines Pharmacy Technician Immunization Immunity 29

Outsourcing Pharma

JUNE 20, 2023

A small molecule compound has shown to induce strong anti-tumor immune responses â an area where medical need is high.

Compounding 52

Compounding Immunity Immunization 52

Pharmaceutical Technology

JUNE 12, 2025

Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Struggles at the drugmaker culminated in long-time CEO Lars Fruergaard Jørgensen stepping down in May 2025.

Diabetes 59

Diabetes Compounding Communication Hospitals 59

Express Pharma

JANUARY 11, 2024

The sales growth of gout therapies across the seven major markets (7MM: the US, 5EU, and Japan) is set to increase at a compound annual growth rate (CAGR) of 8.8 per cent from $4.6 billion in 2022 to $10.8 billion in 2032, in line with the steadily increasing disease prevalence and the entrance of novel agents, according to GlobalData.

Biosimilars 103

Biosimilars Compounding 103

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. A recent report from GlobalData predicted that pharma spending on AI drug discovery would hit $3 billion in 2025.

Compounding 97

Compounding Drug Development 97

pharmacy mentor

JUNE 16, 2025

billion in 2022, and forecasts indicate it will expand at a compound annual growth rate (CAGR) of 20.4% billion by 2025 and could hit USD 69.8 With global and regional markets showing impressive growth rates, it’s clear that online pharmacies are not just a trend — they are shaping the future of healthcare delivery. billion by 2032.

Online Pharmacies 52

Online Pharmacies Customer Service People Management Packaging 52

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

Express Pharma

NOVEMBER 2, 2023

Against this backdrop, the CD drug sales across the eight-major markets (8MM*) are set to increase at a compound annual growth rate (CAGR) of 4.7 The anticipated launches in the US and Europe of Janssen’s Tremfya (guselkumab) and Lilly’s mirikizumab, in Q4 2025 and Q3 2026, respectively, are expected to shape the market.

Biosimilars 100

Biosimilars Compounding 100

Pharmaceutical Business Review

DECEMBER 20, 2024

Assembly Bio CEO and president Jason Okazaki said: Gileads further investment strengthens our balance sheet as we look ahead to multiple key clinical data readouts for our novel antiviral candidates in 2025. In addition, we expect our updated clinical plan for ABI-6250 to significantly reduce the development timeline for the compound.

Compounding 52

Compounding 52

Putting Patients First Blog

JUNE 26, 2025

At the same time, the NHC recommends that CMS avoid incorporating the MFP into ASP calculations, as doing so could depress reimbursement rates across both Medicare and commercial markets, compounding access risks and straining provider viability. 95 (May 15, 2025): 20674, https ://www.federalregister.gov/d/2025-08607.

Drug Pricing 52

Drug Pricing Communication Drug Development Documentation 52

Pharma Marketing Network

APRIL 17, 2025

For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. This article explores why digital investment is escalating, how new platforms and targeting capabilities are reshaping messaging, and what pharma marketers should consider as they navigate the shifting terrain of 2025.

HIPAA 59

HIPAA Drug Pricing Compounding Pharmaceutical Companies 59

Express Pharma

AUGUST 17, 2023

million by 2025. Globally, the systemic antibacterial market, which is growing at a compounded annual growth rate of 4.26 The launch of Elores in Oman is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Gulf Cooperation Council (GCC) member countries as well. “

Compounding 98

Compounding 98

Pharmaceutical Technology

JUNE 18, 2025

Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Anne Cathrine Fleischer, vice president of Global Obesity Consumer Engagement and New Business Models at Novo Nordisk, announced the platform at HLTH Europe. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Communication 52

Communication Hospitals Packaging Compounding 52

Pharmaceutical Technology

JUNE 19, 2025

June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Draig Therapeutics founders: L-R: John Atack, Ruth McKernan and Simon Ward. These compounds have the potential for addressing a spectrum of neuropsychiatric disorders that currently lack adequate treatment options. Credit: Draig Therapeutics/ GlobeNewswire.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Express Pharma

JUNE 5, 2023

billion in 2031 across the 8MM, registering a compound annual growth rate (CAGR) of 1.9 Constellation Pharmaceuticals’ BET inhibitor pelabresib is also set to gain FDA approval in 2025, straight into the first-line setting in combination with Jakafi with the view to improve clinical responses from day 1 of therapy.

Drug Development 97

Drug Development Biosimilars Compounding 97

FDA Law Blog: Biosimilars

JULY 2, 2025

This applies to all “[d]rugs manufactured, prepared, propagated, compounded, or processed in facilities for which fees have not been paid.” Arrears List 2025: A Red Flag for Industry Compliance In June 2025, FDA’s Division of User Fee Management published a 70-page OMUFA Facility Arrears List covering fiscal years 2021 through 2025.

Labelling 52

Labelling Compounding 52

Express Pharma

MARCH 22, 2024

billion by 2025 and approach $84.44 This slow response mechanism further compounds issues Report merging delays: After trials, coordinating for reports across departments becomes a herculean task, delaying the final report dispatch to patrons. By 2020, out of the mammoth $200 billion pumped into pharma research, a whopping $48.4

Compounding 105

Compounding 105

RX Note

APRIL 18, 2025

While the role of the pharmacist as a simple dispenser or compounder may not disappear entirely in the near future, it will likely become less significant. 2024 How and why pharmacists should get involved in clinical research, 2025

Communication 40

Communication Compounding 40

Express Pharma

OCTOBER 16, 2024

The CRO sector in India, growing at a compound annual growth rate (CAGR) of 10.75 Courtesy of contract research organisations (CROs), contract manufacturing organisations (CMOs), and contract development and manufacturing organisations (CDMOs), India’s life sciences sector is rising steadily. per cent, is projected to reach $2.5

Biosimilars 103

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 103

The Thyroid Pharmacist

MAY 15, 2025

coli bacteria from adhering to the walls of the urinary tract, thanks to compounds called proanthocyanidins. [9] Accessed May 7, 2025. Accessed May 8, 2025. Published 2025 Feb 26. Cranberry juice Yes, thats right good old cranberry juice! Cranberry juice may help prevent UTIs by preventing E. Ther Adv Urol. Nature News.

Immunization 59

Immunization Immunity Labelling Compounding 59